Search Results 31-40 of 17294 for GLP-1 therapy
Glucagon-like peptide 1 (GLP-1) receptor agonists. ... Treatment with liraglutide, exenatide or ... Recent clinical trials suggest they may be effective as a ...
By condition, treatment or drug name. Search tips. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes ... GLP-1.
He was one of the early investigators in the GLP 1 therapeutic class of agents which today are mainstays of therapy for both diabetes and obesity. Dr ...
The first, glucagon-like peptide 1 (GLP-1), a gastrointestinal hormone, stimulates the pancreas to make more beta cells, which increases the amount of insulin ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...
Therefore, our overarching goal is to determine the effect of weight loss induced by the new generation of GLP-1 receptor agonists on physical function ...
... GLP-1 is less marked. In this study the investigators propose to randomize ... therapy using FDA-approved weight loss medications and EBMTs with or without ...
The purpose of this study is to determine the contribution of islet GLP-1 to islet function in people with and without diabetes-associated genetic variation in ...
Both RYGB and SG increase GLP-1 concentrations which directly affect B-cell function. Data has shown that the postprandial rise in GLP-1 might affect ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.